A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)

Launched by IFOM ETS - THE AIRC INSTITUTE OF MOLECULAR ONCOLOGY · Oct 20, 2021

Keywords

ClinConnect Summary

The ALFAOMEGA-RETRÒ trial is looking to gather important information about colorectal cancer, a type of cancer that affects the colon or rectum. Researchers will collect past medical records, imaging tests, and tissue samples from patients to better understand the disease and improve treatment options. This study is part of a larger program aimed at uncovering new insights into how colorectal cancer develops and changes over time.

To participate in this trial, individuals must have a confirmed diagnosis of colorectal cancer and be over 18 years old at the time of diagnosis. They also need to have certain medical data and tissue samples available for the study. Participants won't need to attend any new appointments since the study involves reviewing existing information. This trial is currently recruiting patients, and anyone interested should check if they meet the eligibility criteria. Your participation could help researchers develop better treatments for colorectal cancer in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Histologically-confirmed diagnosis of colorectal cancer (any stage).
• • Age \>18 years at the time of diagnosis.
• • Availability of clinically-annotated radio-imaging data and/or diagnostic Formalin-Fixed Paraffin Embedded (FFPE) blocks (surgical resections and/or tumor biopsies), or at least 10 slides (preferably 20). FFPE tissue blocks are always preferred to slides.
• • Verification that the patient could not be reached for informed consent in accordance with applicable national regulations.
• Exclusion Criteria:
• • if inclusion criteria are not met